Gene Query: MRPL4

Dataset Description Geneva Score
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 30.69
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 26.92
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 26.83
Impact of dieldrin on transcription in Jurkat T cells 26.42
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 23.12
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 23.12
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 21.01
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 19.87
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 19.41
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 19.41
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 19.37
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 19.18
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 19.02
The landscape of alternative splicing in aggressive prostate cancers 18.75
Gene expression profiling of leukemia cells following asparagine depletion 18.4
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 18.34
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 18.13
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 17.14
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 16.69
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 16.62
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 16.53
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 16.43
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 16.11
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 16.02
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 16.02
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 15.87
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 15.78
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 15.74
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 15.08
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 14.91
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 14.82
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 14.82
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 14.76
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 14.22
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 14.22
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 14.13
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 14.13
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 14.11
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 14.11
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 13.74
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 13.54
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 13.54
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 13.53
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 13.53
Oncogenic MYC induces a dependency on the spliceosome in human cancer 13.51
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 13.5
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 13.39
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 13.34
Differential gene expression of human melanoma cells [RNA-seq] 13.34
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 13.3
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 13.0
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 12.93
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 12.88
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 12.78
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 12.76
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 12.76
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 12.51
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 12.46
High-Throughput Kinetic Analysis of Fractional Killing 12.36
The comparison of high-throughput single-cell RNA-seq methods 12.34
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 12.24
The cohesin complex prevents Myc-induced replication stress 12.19
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 12.16
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 11.94
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 11.94
Global analysis of enhancer targets: Mosaic-seq 11.89
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 11.76
SETBP1-WT and SETBP1-G870S epigenetic landscapes 11.76
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 11.71
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 11.71
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 11.68
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 11.68
TCF7L1 knockdown in pancreatic cancer 11.64
Role of XRN2 ribonucleolytic activity in RNA metabolism 11.6
Transcriptomic analysis of LSD1 11.48
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 11.27
Transcriptome analysis of SKI knock-out in HL60 cells 11.27
Total RNA-seq in ALL-SIL upon JQ1 inhibition 11.1
Mutational landscape of splicing genes and functional consequences across 33 cancer types 11.04
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 10.89
Expression and functions of long noncoding RNAs during human T helper cell differentiation 10.86
Paxillin regulates genomic networks in prostate cancer [LNCaP] 10.61
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 10.6
Survival of pancreatic cancer cells lacking KRAS function 10.54
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 10.53
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 10.53
Illumina Total RNA-seq in HeLa 10.46
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 10.29
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 10.24
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 10.23
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 10.23
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 10.17
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 10.17
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 10.17
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 10.07
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 9.97
High-throughput sequencing of pluripotent cells 9.95
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 9.93
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 9.9
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 9.9
RNA seq with AML (NB4) cells upon FTO inhibition 9.85
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 9.83
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 9.73
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 9.72
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 9.72
Differentially expressed genes post knock down of lincDUSP26 9.7
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 9.49
Co-regulation of splicing by Rbfox1 and hnRNP M 9.49
hTERT promotes cell adhesion and migration independent of telomerase activity 9.44
METTL3 promotes translation in human cancer cells 9.42
Cajal bodies are linked to genome conformation [RNA-Seq] 9.4
Cajal bodies are linked to genome conformation 9.4
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 9.33
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 9.33
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 9.31
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 9.21
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 8.98
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 8.97
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 8.96
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 8.93
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 8.89
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 8.72
RNA splicing alteration on glioblastoma and normal neural stem cells 8.66
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 8.63
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 8.63
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 8.62
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 8.56
miR941 overexpression experiment 8.56
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 8.52
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 8.52
Loss of CREBBP results in gene expression repression in lymphoma cells 8.52
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 8.52
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 8.51
Identification of transcription start sites for human A549 cell line using ReCappable-seq 8.5
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 8.44
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 8.42
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 8.42
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 8.4
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 8.4
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 8.38
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 8.32
EWSR1 influences alternative splicing through direct and indirect mechanisms 8.3
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 8.26
Lysine benzoylation is a novel histone mark [RNA-seq] 8.19
Lysine benzoylation is a novel histone mark 8.19
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 8.17
A map of gene expression in neutrophil-like cell lines 8.15
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 8.15
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 8.14
Effect of FGF13 depletion on the H460 cell line 8.12
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 8.12
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 8.11
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 8.04
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 8.03
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 8.01
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 7.98
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 7.87
SLAM-seq for K562 endogenous mRNA decay 7.8
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 7.78
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 7.76
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 7.76
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 7.74
Gene expression analysis of the impact of TDP-43 knockout in human cells. 7.74
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 7.73
G-quadruplex structures mark human regulatory chromatin 7.72
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 7.69
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 7.69
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 7.69
N6-methyladenine DNA Modification in Glioblastoma 7.68
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 7.68
scRNASeq analysis of cycling cardiomyocytes 7.67
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 7.64
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 7.63
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 7.63
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 7.57
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 7.55
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 7.52
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 7.45
RNA-seq analysis of RALD iPSCs after in vitro differentiation 7.45
Selective expression of long non-coding RNAs in a breast cancer cell progression model 7.44
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 7.42
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 7.42
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 7.38
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 7.38
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 7.36
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 7.35
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 7.33
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 7.33
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 7.32
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 7.3
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 7.3
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 7.21
RNA-seq analysis of differentiating human erythroblasts 7.21
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 7.19
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 7.16
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 7.14
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 7.14
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 7.14
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 7.14
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 7.14
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  7.07
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 7.04
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 7.02
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 7.0
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 6.99
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 6.99
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 6.97
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 6.96
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 6.93
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 6.92
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 6.92
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 6.86
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 6.82
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 6.81
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 6.78
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 6.78
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 6.75
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 6.72
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 6.67
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 6.67
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 6.66
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 6.61
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 6.61
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 6.6
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 6.6
RNA sequencing of primary human platelets and in vitro cell lines 6.57
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 6.56
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 6.51
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 6.51
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 6.49
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 6.49
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 6.47
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 6.45
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 6.4
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 6.4
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 6.37
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 6.37
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 6.37
RNA-seq analysis of control and Myc-induced U2OS cells 6.33
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 6.3
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 6.25
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 6.25
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 6.22
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 6.22
The DPYSL2 gene connects mTOR and schizophrenia 6.17
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 6.16
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 6.16
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 6.14
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 6.06
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 6.03
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 6.02
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 6.0
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 6.0
Human Treg NaCl stimulation 5.99
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 5.94
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 5.94
Transcriptome profiling of 5 human adenocarcinoma cell lines 5.92
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 5.84
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 5.82
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 5.82
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 5.79
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 5.79
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 5.77
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 5.73
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 5.72
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 5.69
Landscape and variation of RNA secondary structure across the human transcriptome 5.62
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 5.6
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 5.59
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 5.57
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 5.57
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 5.55
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 5.55
PRDM1 inhibits proliferation of human colon cancer organoids 5.52
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 5.48
Regulation of hypoxia-inducible factor activity by ZMYND8 5.48
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 5.46
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 5.35
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 5.35
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 5.34
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 5.32
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 5.32
Targeting MTHFD2 in Acute Myeloid Leukemia 5.31
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 5.3
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 5.29
Regulation of poly(A) tail and translation during the somatic cell cycle 5.26
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 5.25
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 5.25
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 5.24
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 5.2
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 5.17
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 5.14
SRSF1 role in cellular gene expression and splicing 5.11
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 5.1
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 5.07
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 5.04
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 5.04
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 5.04
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 5.0
RNAseq of cell lines with knocked in ESR1 mutations 4.98
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 4.96
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 4.93
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 4.9
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 4.85
Tracing Enhancer Networks using Epigenetic Traits (TENET) 4.77
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 4.76
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 4.73
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 4.69
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 4.67
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 4.66
Microprocessor mediates transcription termination in long noncoding microRNA genes 4.6
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 4.59
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 4.58
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 4.57
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 4.55
Hijacking of stress response machinery by oncogenes in acute leukaemia 4.54
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 4.54
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 4.54
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 4.49
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 4.44
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 4.43
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 4.43
KLF6-dependent transcription in renal cancer cells 4.39
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 4.37
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 4.37
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 4.37
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 4.33
Aneuploidy-induced cellular stresses limit autophagic degradation. 4.33
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 4.31
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 4.31
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 4.31
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 4.27
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 4.2
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 4.2
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 4.17
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 4.12
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 4.1
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 4.1
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 4.09
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 4.07
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 4.07
Ribosome profiling upon inhibition of eIF4A 4.06
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 4.01
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 3.98
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 3.98
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 3.97
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 3.85
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 3.79
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 3.79
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 3.75
ARID1A and ARID1B loss in HCT116 and TOV21G cells 3.73
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 3.69
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 3.61
ChIP-seq and RNA-seq from human lymphoma cell lines 3.61
RNA-seq data from human lymphoma cell lines 3.61
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 3.6
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 3.55
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 3.55
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 3.49
Positively selected enhancer elements endow tumor cells with metastatic competence 3.44
Ribosomal protein RPL26 is the principal target of UFMylation 3.39
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  3.39
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 3.25
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 3.23
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 3.22
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 3.22
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 3.21
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 3.15
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 3.13
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 3.12
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 3.08
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 3.0
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 3.0
RNA-seq analysis upon ARID1B overexpression 2.98
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 2.93
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 2.92
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 2.87
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 2.81
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 2.8
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 2.79
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 2.79
Transcriptome analysis upon C6orf203 silencing 2.77
Function and hormonal regulation of GATA3 in human first trimester placentation 2.76
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 2.73
miRNAs affected by antagomiR-17 treatment 2.64
Functional role of CPPED1 in trophoblasts. 2.63
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 2.63
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 2.61
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 2.6
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 2.59
MARCKS and lnc-MARCKS act as inflammation regulators 2.53
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 2.51
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.47
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.47
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 2.45
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 2.37
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 2.37
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 2.36
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 2.33
Effect of PBK knockdown on C4-2 cell transcriptome 2.32
Gene expression analysis upon mtDNA depletion 2.31
Gene expression analysis upon mtDNA depletion [RNA-seq] 2.31
RNA-Seq of PRMT1 overexpression ECA109 cells 2.31
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 2.22
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 2.21
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 2.15
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 2.15
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 2.14
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 2.12
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 2.12
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 2.12
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 2.06
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 2.05
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 2.02
Transcriptomic analysis of human tonsillar TFH subsets 2.01
Comparative Analysis of Cas9 Activators Across Multiple Species 1.99
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.95
Gene expression profile in breast cancer cells 1.95
MYCi975 regulates MYC target genes 1.93
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.93
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 1.93
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.92
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 1.89
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 1.82
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 1.79
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 1.77
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 1.69
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.68
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 1.67
Investigate A2M treatment on human prostate cancer xenograft in mice 1.55
Investigate A2M treatment on human prostate cancer and mouse liver 1.55
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.51
Downregulation of LATS kinases alters p53 to promote cell migration 1.51
Human Treg IFNg/IL-10 subpopulations 1.48
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 1.36
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 1.26
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 1.26
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.25
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 1.24
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.21
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 1.17
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 1.14
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 1.14
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.12
The transcriptome effect of overexpressing EZH2 in MCF7 1.09
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.07
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.05
Profiling of escape kinetics of viruses subjected to RNAi 1.02
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 1.0
Impact on erythroid progenitor type on erythroid differntiation 0.99
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.93
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.91
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.91
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.88
EGR1-controlled transcriptome of T HESCs 0.85
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.84
mRNA differential expression analysis in a human ex vivo model of chronic wounds 0.83
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.78
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.78
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.77
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.74
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.71
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.7
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.7
Transcriptome sequencing of K-562 cells 0.65
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.65
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.65
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.62
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 0.59
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.57
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.54
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.5
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 0.38
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 0.38
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 0.37
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.35
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.32
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.28
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.28
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.28
The circadian transcriptional landscape in primary human mammary epithelial cells 0.23
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.2
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.2
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.18
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.18
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.17
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.15
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 0.14
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.12
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.12
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.1
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.1
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.06
MHC Transcriptomic landscape at haplotype-specific resolution 0.05
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.05
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.04
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.03
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 0.03
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.02
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation